Publication | Closed Access

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression

Breast OncologyMedicinePharmacologyPhase Ii StudyWeekly PaclitaxelBreast CancerAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyNeoadjuvant Chemotherapy